Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Shanghai Green Valley Pharmaceuticals
Pharma
Hengrui, Merck-Kelun, Dr. Reddy's and more—Fierce Pharma Asia
Hengrui debuts global startup. Merck signs a potential $1.4 billion deal for a Chinese firm's cancer program. Dr. Reddy's sees growth in Russia.
Angus Liu
May 20, 2022 9:15am
Trial for controversial China-made Alzheimer's drug aborted
May 13, 2022 4:16pm
Biogen, Pfizer, Lilly and more win China NRDL coverage
Dec 3, 2021 10:15am
AstraZeneca, GSK, I-Mab and more—FiercePharmaAsia
May 1, 2020 8:45am
Did this obscure Chinese firm just break the Alzheimer's curse?
Nov 4, 2019 11:13am
